Having a parent who lives to 100 or beyond may confer significant health advantages to their children, according to a new analysis of long-running studies in the United States and the United Kingdom. The research, which pooled data from more than 4,000 participants, found that offspring of centenarians had a markedly lower risk of dying early and developing cardiovascular disease compared with those whose parents died younger.
Lower risks across major health outcomes
In the combined analysis, people with at least one parent who reached 100 had a 42% lower hazard of death from any cause, a 33% lower hazard of cardiovascular disease, and a 32% lower hazard of high blood pressure. Their mortality was delayed by about three years on average, and the onset of hypertension was pushed back by roughly five years.
Cardiovascular disease remains the leading cause of death globally, accounting for 42.5% of all deaths in the World Health Organization European Region in 2019. High blood pressure is the region's top risk factor, contributing to 24% of cardiovascular deaths that year. These new findings, published in the Journal of the American College of Cardiology, could have particular relevance for European health systems grappling with aging populations.
The protective effect was not uniform across all conditions. Stroke risk was lower in two of the three cohorts, but the researchers found no significant difference in cancer risk. This suggests that the longevity advantage may be specific to cardiovascular health rather than a blanket shield against all age-related diseases.
Beyond lifestyle factors
The results held even after adjusting for smoking, education, and, where data were available, diet, exercise, alcohol use, and socioeconomic status. This implies that lifestyle differences alone cannot explain the observed benefits. "The fact that the association persists after controlling for these factors points to a possible genetic or epigenetic component," said Dr. Sofie Nilsson, a geriatrician at Karolinska University Hospital in Stockholm, who was not involved in the study.
Centenarians are already known to develop age-related diseases much later than the general population. By studying their children, researchers hope to identify the genetic and environmental factors that contribute to a longer period of healthy life. "Children of centenarians are a unique window into the biology of aging," said lead author Dr. Emily Chen of the University of California, San Francisco.
However, the study is observational and cannot establish causation. "We cannot say that having a centenarian parent directly causes these benefits," Chen cautioned. "But the data provide a strong signal that warrants further investigation."
The findings add to a growing body of research on longevity, which has also explored the impact of extreme heat on health and other environmental factors. While the study was based on US and UK cohorts, its implications are global, and European researchers are already planning similar analyses using data from the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
For now, the message for the public is clear: while you cannot choose your parents, understanding what makes centenarians' children resilient could one day lead to interventions that help more people live longer, healthier lives. As Dr. Nilsson put it, "This is not about predicting your fate, but about uncovering the mechanisms that protect some individuals—and potentially applying them to everyone."
